HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
Clinical trial NCT05632861 · RECRUITING
Trial details
- NCT number
- NCT05632861
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-12-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.